IL237498B - Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium - Google Patents
Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesiumInfo
- Publication number
- IL237498B IL237498B IL237498A IL23749815A IL237498B IL 237498 B IL237498 B IL 237498B IL 237498 A IL237498 A IL 237498A IL 23749815 A IL23749815 A IL 23749815A IL 237498 B IL237498 B IL 237498B
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- methods
- drug delivery
- delivery systems
- urinary tract
- Prior art date
Links
- 208000026723 Urinary tract disease Diseases 0.000 title 1
- 238000012377 drug delivery Methods 0.000 title 1
- 230000004064 dysfunction Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 208000014001 urinary system disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261702576P | 2012-09-18 | 2012-09-18 | |
| PCT/US2013/060479 WO2014047221A1 (en) | 2012-09-18 | 2013-09-18 | Drug delivery systems and methods for treatment of bladder voiding dysfunction|and other lower urinary tract disorders by using trospium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL237498A0 IL237498A0 (en) | 2015-04-30 |
| IL237498B true IL237498B (en) | 2018-01-31 |
Family
ID=49301639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL237498A IL237498B (en) | 2012-09-18 | 2015-03-02 | Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10500200B2 (https=) |
| EP (1) | EP2897616A1 (https=) |
| JP (2) | JP6600256B2 (https=) |
| KR (1) | KR102141433B1 (https=) |
| CN (2) | CN104684556A (https=) |
| AU (1) | AU2013318146B2 (https=) |
| BR (1) | BR112015005351A2 (https=) |
| CA (1) | CA2883855C (https=) |
| IL (1) | IL237498B (https=) |
| MX (2) | MX379066B (https=) |
| RU (1) | RU2670749C9 (https=) |
| SG (1) | SG11201502104YA (https=) |
| WO (1) | WO2014047221A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| SG11201501424SA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin |
| MX367070B (es) | 2012-08-31 | 2019-08-05 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. |
| MX379066B (es) * | 2012-09-18 | 2025-03-04 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
| LT4124339T (lt) | 2014-03-06 | 2025-11-10 | Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu | |
| CN106573133B (zh) * | 2014-08-19 | 2020-03-03 | 加利福尼亚大学董事会 | 用于局部药物递送的植入物及其使用方法 |
| GB201506526D0 (en) | 2015-04-17 | 2015-06-03 | Uropharma Ltd And Synesis Llc | Medicinal composition |
| CN106706832A (zh) * | 2015-08-06 | 2017-05-24 | 舒泰神（北京）生物制药股份有限公司 | 一种测定曲司氯铵含量的方法 |
| PT3432970T (pt) | 2017-02-01 | 2021-05-26 | Taris Biomedical Llc | Dispositivos de administração de fármaco in vivo |
| BR112020000832A2 (pt) | 2017-07-25 | 2020-07-21 | Taris Biomedical Llc | métodos para tratar metástase tumoral |
| TWI841554B (zh) | 2018-03-21 | 2024-05-11 | 丹麥商珍美寶股份有限公司 | 以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法 |
| WO2019217455A1 (en) | 2018-05-07 | 2019-11-14 | Genmab A/S | Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate |
| CN112839653A (zh) * | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
| TWI844571B (zh) | 2018-10-30 | 2024-06-11 | 丹麥商珍美寶股份有限公司 | 使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法 |
| AU2020265812B2 (en) * | 2019-04-30 | 2025-08-28 | Trigone Pharma Ltd. | Formulations and methods for drug instillation into the bladder and treatment of bladder ailments |
| US11173291B2 (en) | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| JP7665645B2 (ja) | 2020-03-20 | 2025-04-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 局所的な薬物送達のための移植可能な薬物送達デバイス |
| US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| US11338119B2 (en) | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
| KR102596697B1 (ko) | 2021-05-20 | 2023-11-01 | 김정우 | 바위솔 추출물을 유효성분으로 포함하는 화장품 조성물 및 그 제조 방법 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2125696T3 (es) * | 1996-11-27 | 1999-03-01 | Pfleger R Chem Fab | Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. |
| EP1424079A1 (en) * | 2002-11-27 | 2004-06-02 | Boehringer Ingelheim International GmbH | Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine |
| US20060058777A1 (en) * | 2002-12-11 | 2006-03-16 | Pia Norup Nielsen | Urinary catheter device with a pharmaceutically active composition |
| WO2004064789A2 (en) | 2003-01-16 | 2004-08-05 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| ES2322148T3 (es) | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
| WO2006101954A2 (en) * | 2005-03-17 | 2006-09-28 | Indevus Pharmaceuticals, Inc. | Interstitial cystitis treatment |
| US7390816B2 (en) | 2005-06-21 | 2008-06-24 | Bridge Pharma, Inc. | Methods for treating urinary incontinence in patients suffering from memory disorders |
| DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| EP1967202A1 (en) | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
| KR101538748B1 (ko) | 2007-12-11 | 2015-07-22 | 메사추세츠 인스티튜트 오브 테크놀로지 | 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법 |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| DK2445570T3 (da) | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| PL3884988T3 (pl) | 2009-12-17 | 2025-09-08 | Taris Biomedical Llc | Urządzenie implantowalne z tolerancją wewnątrzpęcherzową |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| WO2012048114A1 (en) * | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| EP2670398B1 (en) * | 2011-02-04 | 2017-06-07 | TARIS Biomedical LLC | Implantable device for controlled release of low solubility drug |
| MX379066B (es) * | 2012-09-18 | 2025-03-04 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
| KR102557326B1 (ko) | 2013-03-15 | 2023-07-19 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 |
-
2013
- 2013-09-18 MX MX2015003110A patent/MX379066B/es unknown
- 2013-09-18 CN CN201380046758.2A patent/CN104684556A/zh active Pending
- 2013-09-18 CA CA2883855A patent/CA2883855C/en active Active
- 2013-09-18 JP JP2015532177A patent/JP6600256B2/ja active Active
- 2013-09-18 RU RU2015112196A patent/RU2670749C9/ru active
- 2013-09-18 EP EP13771696.5A patent/EP2897616A1/en active Pending
- 2013-09-18 SG SG11201502104YA patent/SG11201502104YA/en unknown
- 2013-09-18 KR KR1020157008403A patent/KR102141433B1/ko active Active
- 2013-09-18 BR BR112015005351A patent/BR112015005351A2/pt not_active Application Discontinuation
- 2013-09-18 WO PCT/US2013/060479 patent/WO2014047221A1/en not_active Ceased
- 2013-09-18 CN CN202010161062.6A patent/CN111450093A/zh active Pending
- 2013-09-18 AU AU2013318146A patent/AU2013318146B2/en not_active Ceased
-
2015
- 2015-03-02 IL IL237498A patent/IL237498B/en active IP Right Grant
- 2015-03-11 MX MX2020002465A patent/MX2020002465A/es unknown
- 2015-03-16 US US14/658,699 patent/US10500200B2/en active Active
-
2018
- 2018-02-02 JP JP2018017300A patent/JP2018080208A/ja active Pending
-
2019
- 2019-12-06 US US16/706,009 patent/US11850244B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2015529688A (ja) | 2015-10-08 |
| CA2883855C (en) | 2020-09-15 |
| JP6600256B2 (ja) | 2019-10-30 |
| CN111450093A (zh) | 2020-07-28 |
| CA2883855A1 (en) | 2014-03-27 |
| BR112015005351A2 (pt) | 2017-07-04 |
| IL237498A0 (en) | 2015-04-30 |
| RU2015112196A (ru) | 2016-11-10 |
| MX2020002465A (es) | 2020-07-13 |
| WO2014047221A9 (en) | 2015-05-21 |
| SG11201502104YA (en) | 2015-05-28 |
| JP2018080208A (ja) | 2018-05-24 |
| WO2014047221A1 (en) | 2014-03-27 |
| EP2897616A1 (en) | 2015-07-29 |
| AU2013318146B2 (en) | 2018-05-10 |
| RU2670749C2 (ru) | 2018-10-25 |
| KR20150058271A (ko) | 2015-05-28 |
| RU2670749C9 (ru) | 2018-12-13 |
| MX2015003110A (es) | 2015-06-05 |
| US20150182516A1 (en) | 2015-07-02 |
| CN104684556A (zh) | 2015-06-03 |
| MX379066B (es) | 2025-03-04 |
| AU2013318146A1 (en) | 2015-03-19 |
| US20200108057A1 (en) | 2020-04-09 |
| KR102141433B1 (ko) | 2020-08-05 |
| US11850244B2 (en) | 2023-12-26 |
| US10500200B2 (en) | 2019-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL237498B (en) | Drug delivery systems and methods for treating bladder emptying dysfunction and other lower urinary tract disorders using tropesium | |
| PT2600800T (pt) | Dispositivo de administração de drogas por stent ureteral, kit e método | |
| EP2528648A4 (en) | CATHETER DEVICES AND DRAINAGE SYSTEMS FOR THE DELIVERY OF THERAPEUTIC AGENTS | |
| EP2785275A4 (en) | TREATMENT OF HARNINE CONTINENCE | |
| EP2413917A4 (en) | DRUG DELIVERY SYSTEM AND METHODS OF USING THE SAME | |
| IL239557B (en) | Microarray for providing therapeutic material and methods for use | |
| IL227576A0 (en) | Highlighting materials in mri, transfer and extraction systems, and methods of production and use thereof | |
| EP2675402A4 (en) | BLOOD FLOW INTERFERENCE DEVICES AND METHOD FOR THE TREATMENT OF VASCULAR DEFECTS | |
| EP2782631A4 (en) | IMPLANTABLE APPARATUS FOR USE IN THE ADMINISTRATION OF A SOLID-LIQUID MEDICAMENT, ASSOCIATED FORMULATIONS AND METHODS OF USE | |
| PT2440230T (pt) | Regimes de tratamento para tratamento de doenças neurológicas | |
| IL237281B (en) | Drug delivery systems and methods for treating bladder cancer comprising oxaliplatin | |
| IL227312A0 (en) | Lidocaine administration regimen for long-term treatment of bladder pain and voiding irritation | |
| IL237300A0 (en) | Drug delivery systems and methods for treating prostate gland diseases containing gemcitabine | |
| EP2553639A4 (en) | SYSTEMS AND METHODS FOR MANAGING THE TREATMENT OF ORPHAN DISEASE | |
| IL254446A0 (en) | Implantable drug delivery preparations and treatment methods thereof | |
| ZA201400348B (en) | Catheter,particularly an indwelling catheter,for treating functional problems and/or diseases of the bladder and/or prostate | |
| EP2755686A4 (en) | METHODS AND SYSTEMS FOR MANUFACTURING MICRO-TABLETS FOR USE IN THE DELIVERY OF MEDICAMENTS | |
| PL3153511T3 (pl) | Pochodna 2-acyloaminotiazolu do stosowania do profilaktyki lub leczenia chorób pęcherza moczowego/dróg moczowych | |
| HUE038580T2 (hu) | Hatóanyag bejuttató rendszer neurológiai rendellenességek kezelésében, vagy diagnózisában való felhasználásra | |
| EP2790637A4 (en) | VAGINAL DRUG DELIVERY DEVICES AND METHODS OF MANUFACTURING THE SAME | |
| ZA201502288B (en) | Ciclesonide for treatment of airway disease in horses | |
| IL239308A0 (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| EP2640468A4 (en) | ADMINISTRATIVE AND TREATMENT PROCEDURES | |
| IL227921A0 (en) | Methods for prognosis and treatment of inflammatory disorders | |
| IL231052B (en) | Bacteriochlorophyll photosensitizers for the treatment of eye diseases and disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |